Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001415889-19-000017)

Filing Details

Accession Number:
0001415889-19-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-02 18:47:53
Reporting Period:
2018-12-28
Accepted Time:
2019-01-02 18:47:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604191 Azurrx Biopharma Inc. AZRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535289 M. Johan Spoor
Suite 304
Brooklyn NY 11226		 President And Ceo No No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-28 38,583 $1.30 338,617 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 39,851 Indirect By Mother as custodian under UTMA for children